Identifying Barriers and Facilitators to Pain Management With Buprenorphine for Patients With Kidney Failure: A Thematic Analysis of Interviews With Key Partners.

ABSTRACT:

Rationale & objective

Treating pain with analgesic medications in patients with kidney failure receiving dialysis is often complicated owing to altered pharmacokinetics, affecting efficacy and safety of medications. Buprenorphine, a partial opioid agonist without these limitations, has potential value in pain treatment in kidney failure. The aim of this qualitative study was to identify barriers and facilitators to overcoming stigma for implementation of buprenorphine as a pain treatment in patients treated with dialysis.

Study design

Thematic analysis of interview data.

Setting & participants

We used snowball sampling to enroll physicians with expertise in pain management and kidney failure, and other key partners.

Exposures

Participants completed semistructur

SUBMITTER: Kallem CJ 

PROVIDER: S-EPMC12664035 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature